Antibodies directed against human follicle-stimulating hormone (FSH) were demonstrated in rabbit serum by neutralization of biological activity. Antibodies that bound FSH-131 I were produced in rabbits and guinea pigs by repeated injections of FSH. By 131 I immunochemical methods, we found that at least 90% of the FSH-131 I-binding antibody failed to distinguish the four human glycoprotein hormones: FSH, luteinizing hormone, chorionic gonadotropin, and thyrotropin, purified as well as endogenous hormone in plasma. Neither growth hormone, adrenocorticotropin, nor a variety of glycoproteins or animal plasmas were able to react with these antibodies.
INTRODUCTION
Because the pituitary gonadotropins, folliclestimulating hormone (FSH), and luteinizing hormone (LH) have routinely been measured by tedious, imprecise, and relatively insensitive bioassays on extracts of urine, many workers are investigating 1311-immunoassay methods (2) for the measurement of gonadotropins in plasma. In attempting to develop such an assay for plasma FSH, we noted that rabbit and guinea pig anti-FSH reacted not just with FSH but with three other glycoprotein trophic hormones: LH, thyrotropin (TSH), and human chorionic gonadotropin Received for publication 17 October 1967 and in revised form 6 March 1968. (HCG). We report here the results of studies of this unusual cross-reaction.
METHODS
Hormones and plasmas were of human origin except as noted. Biologic potency of the FSH preparations 1 listed in Fig. 1 was measured by the rat ovarian weight augmentation assay (3) ; FSH from sheep pituitaries (NIH-FSH-S1)2 was used as a standard, and the data were expressed in International Units (IU).5 FSH (PC-21-8A1) was prepared by Dr. Peter Condliffe by extraction of an acetone powder of human pituitary glands with 57% ethanol-5%o sodium chloride, by gel filtration of the dialyzed extract on Sephadex G-50, followed by chromatography on carboxymethyl cellulose. Material unadsorbed from a solution of 0.01 M ammonium acetate, pH 5.3 (PC-21-8A1), was further purified by filtration on Sephadex G-100 (T-II). Thyrotropin (TSH), 10 lU/mg,4 luteinizing hormone (LH), 5 NIH-LH-S1 U/mg,5 and human chorionic gonadotropin (HCG)6 were not further 1 Gifts of Dr. Leo Reichert (LER), Department of Biochemistry, Emory University, Atlanta, Ga., through the National Pituitary Agency, Baltimore, Md., Dr purified. Rabbit gamma globulin (RGG) was purified by chromatography on diethylaminoethyl cellulose. 7 Antibodies to FSH were induced in rabbits (New Zealand strain, 1.5 kg) and guinea pigs (both National Institutes of Health [NIH] and Hartley strains, 250 g) with either PC-21-8A1 or LER 677-4. The hormones, 1 mg/ml in saline, were emulsified with an equal volume of Freund's complete adjuvant 8 and 5-15 IU injected subcutaneously at intervals of 2 or more wk for five or more injections. The animals were bled 2 wk after the fifth and subsequent injections. Antisera to rabbit and to guinea pig gamma globulin9 were obtained from sheep after intramuscular injections of 100 mg.
FSH (Reichert, LER 710-2), LH (Hartree), and HCG (Bagshawe) were iodinated with carrier-free 10 'iodide to specific activities of 100-150 /uc/gg and human serum albumin (HSA)" and RGG (Metzger) to specific activities of 10-20 Ac/,ug by the chloramine-T method (4) . Unreacted iodide was removed by batch adsorption with an anion exchange resin (Dowex l-X10); other minor radioactive contaminants were removed by gel filtration on Sephadex G-100 or by electrophoresis in starch gel.
The diluent for all experiments was sodium phosphate buffer (0.05 moles/liter, pH 7.4) to which was added bovine serum albumin (2.5 mg/ml), sodium azide (1.0 mg/ml), and plasma from a patient with panhypopituitarism at a final dilution of 1:100. For the assay of FSH a series of solutions were prepared each of which contained FSH-"I (0.05-0.1 mug/ml), rabbit anti-FSH (usually at a final dilution of 1: 100,000), and unlabeled FSH (over the range of 0-100 msg/ml). The total volume of each solution was 1.0 ml. After 4 days at 4°C, 0.15 ml of sheep anti-RGG and 0.1 ml of a 1: 20 dilution of nonimmune rabbit plasma containing 0.1 M ethylenediaminetetraacetate (5) were added to each solution. 1 day later the solutions were centrifuged, the supernatants discarded, and the radioactivity of the drained but unwashed sediments determined in a well-type scintillation counter. For the assay of FSH in plasma, an aliquot of plasma (0.1 ml or less) was substituted for the unlabeled hormone. The hormone concentration in plasma was determined by comparing radioactivity precipitated from the plasma sample with radioactivity precipitated from solutions containing known quantities of unlabeled FSH (standard curve), and was expressed in millimicrograms per milliliter of FSH (LER 710-2).
When nonimmune rabbit serum was substituted for 
RESULTS
The purity of FSH (LER 710-2) was evaluated by vertical electrophoresis in starch gel (6) in a discontinuous buffer system (tris [hydroxymethyl] aminomethane-citrate-borate, pH 8.6) and by electrophoresis in polyacrylamide gel (7.5%, pH 9.5) (7). In both systems two bands were seen with amido black lOB; the major band (about 90%) appeared just cathodal to albumin, whereas the minor band was coincident with albumin. Assay of eluates from serial slices of an acrylamide gel showed that all of the FSH biological activity was in the major band. Purity of the FSH-131I was evaluated as follows: (a) FSH-131I on electrophoresis in starch and in acrylamide had a mobility indistinguishable from that of the major band of unlabeled FSH. To demonstrate anti-FSH antibodies in the plasma of immune rabbits by neutralization of FSH activity several precautions were necessary. Thus, in the standard bioassay for 'FSH (3) intact immature rats receive 1-6 IU of FSH and a fixed dose of HCG (e.g., 50 IU); the increase in weight of the ovaries is a function of the amount of FSH injected. However, the responsiveness of the ovaries to FSH is highly dependent on the dose of HCG, and in the absence of HCG, FSH causes no increase in ovarian weight. Since the FSH used for immunization contained LH, the immune serum presumably also contained anti-LH antibodies which bind both LH and HCG (8, 9) . Thus apparent neutralization of FSH activity by such an antiserum could arise either from binding of FSH or from binding of HCG. This ambiguity was avoided by using hypophysectomized immature rats since the response of the ovaries to FSH Antibody to Human Follicle-Stimulating Hormone (Fig. 2) . All preparations of FSH tested, from pituitary powder to highly purified material, yielded curves of displacement that were qualitatively identical (Fig. 1) i.e., were superimposable when the abscissa was suitably adjusted. Over a 10-20-fold range of dilution, plasma from patients with gonadal insufficiency 13 or with gonadotropinproducing carcinoma of the lung (11) crossreacted identically with purified FSH.
But highly purified preparations of LH, TSH, and HCG, containing little or no FSH, also displaced FSH-'311 from the rabbit and from the guinea pig anti-FSH sera in a manner qualitatively and quantitatively identical with the displacement by pure unlabeled FSH (Fig. 2) 14 In addition to the data in Fig. 2 , the cross-reactions were confirmed repeatedly with purified LH in antisera from nine rabbits and four guinea pigs, purified HCG in four rabbits, and plasma TSH in two rabbits. 15 (Table II) .
The data from several experiments were recalculated to determine what fraction of the total FSH-131I binding capacity was being examined (Fig. 4) Thus the data here are reported in terms of LER-780, whose preparation and biological potency were about the same as the original LER 710-2.
t Samples from the middle of the menstrual cycle were excluded. § Assayed by the mouse uterine weight method.
1 1 "FSH" fell promptly to very low levels after estrogen was injected intravenously. This patient also had an isolated deficiency of thyrotropin (TSH). ¶ In one postmenopausal patient hypophysectomy was followed by a fall in plasma "FSH" from 30 to 1. FIGURE 4 Binding capacity of antiserum for FSH and HCG. Data from three experiments with a single antiserum were combined. Corrections were applied for the radioactivity in the supernate that was immunologically unreactive and for radioactivity in the precipitate that was not bound to the antibody. The bound/ free of FSH-1lI was plotted as a function of the concentration of unlabeled hormone that was bound to the FSH-~I binding antibody (12, 13) . Since all the experiments were performed at 1: 100,000 dilution of antiserum, data in the figure were multiplied by 10 to yield binding capacity per milliliter of antiserum. 1.0 for the hormones with a binding capacity of [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ,ug/ml of antiserum. investigators have found some sera with low concentrations of antibodies that bind FSH much more strongly than the other hormones (14-16). Franchimont, the first investigator to report a radioimmunoassay of FSH in plasma, did not report studies of the cross-reaction of LH and HCG with his antiserum, either by radioimmunoassay or by biological neutralization (17) . However, he and others have noted that rabbit anti-HCG and rabbit anti-LH bind LH and HCG but react only slightly with TSH and FSH (18) . Likewise we found that rabbit anti-HCG bound HCG-131I and LH-1311 equally well, and both were displaced identically with unlabeled HCG and LH. FSH was less than one-tenth as potent. Similarly, others have reported that rabbit anti-TSH crossreacts only weakly and incompletely with urinary gonadotropins (a mixture of FSH and LH) and with purified HCG (19) . Therefore it would appear that our anti-FSH antibodies have the broadest cross-reactivity of any of the antihormone sera examined thus far. Because experimental conditions and reagents vary among laboratories, further studies are needed before the breadth of specificity of anti-LH, anti-HCG, and anti-TSH sera is definitely established.
Immunological cross-reactivity has been observed and easily explained among hormones known to have regions of identical structures or biological activities in common (e.g., arginine and lysine vasopressin, human growth hormone and human placental lactogen, LH and HCG, adrenocorticotropin and melanocyte-stimulating hormone). However, our finding of a significant cross-reaction of these hormones with at least the vast majority of the FSH-131I binding antibody in all of many sera from different animals is striking, particularly since the biological activities of these hormones are distinct, and the chemical differences are well described. These include total carbohydrate content, proportions of individual sugars, inactivation studies and behavior on electrophoresis and on substituted celluloses (20, 21) .
In view of the poor reactivity of FSH with the antibody to the other hormones, and the same approximate size of the four hormones (mol wt roughly 30,000-40,000), our findings lead us to suggest that FSH has sites whose peculiar structures endow them with inordinately more immunogenicity than the remainder of the molecule, and these few sites are similar to regions on the other three hormones. Among the less likely possibilities are (a) all four hormones have many regions in common, (b) the FSH molecule, analogous to alpha melanocyte-stimulating hormone and adrenocorticotropin, is represented in toto as a part of the larger structure of the other hormones, (c) FSH is largely composed of one or a few serially repeating structures that are also found to some extent in the other three hormones.
